[1] COLLINS K, MITCHELL J R. Telomerase in the human organism. 2002(4). doi:10.1038/sj.onc.1205083
[2] OHKI R, ISHIKAWA F. Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats. 2004(5). doi:10.1093/nar/gkh309
[3] KUIMOV A N. Polypeptide components of telomere nucleoprotein complex. 2004(2)
[4] COLGIN L M, BARAN K, BAUMANN P. Human pot1 facilitates telomere elongation by telomerase. 2003(4)
[5] AZZALIN C M, LINGNER J. Telomere wedding ends in divorce. 2004(5667). doi:10.1126/science.1096809
[6] DYNEK J N, SMITH S. Resolution of sister telomere association is required for progression through mitosis. 2004(5667). doi:10.1126/science.1094754
[7] CHANG J T C, CHEN Y L, YANG H T. Differential regulation of telomerase activity by six telomerase subunits. 2002(14)
[8] MASON P J. Stem cells telomerase and dyskeratosis congenital. 2003(2). doi:10.1002/bies.10229
[9] STEWART S A, WEINBERG R A. Senescence:does it all happen at the ends-. 2002(4). doi:10.1038/sj.onc.1205062
[10] PARK N H, GUO W, KIM H R. c-myc and sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter. 2001(4)
[11] WEGE H, CHUI M S, LE H T. SYBR green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. 2003(2). doi:10.1093/nar/gng003
[12] HESS J L, HIGHSMITH W E. Telomerase detection in body fluids. 2002(1)
[13] KAMRADT J, DROSSE C, KALKBRENNER S. Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer:a real-time quantification and in suit hybidization study. 2003(5)
[14] LEHNER R, ENOMOTO T, MC-GREGOR J A. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. 2002(1). doi:10.1006/gyno.2001.6474
[15] GIL M E, COTZER T L. Real-time qualitative RT-PCR for human telomere elongationreverse transcriptate in chronic myeloid leukemia. 2004(9). doi:10.1016/j.leukres.2004.01.002
[16] CUI W, CHEN J M. Telomere dynamics of leukocytes in bone marrow with leukemia and myelodysplastic syndromes by flow cytometry. Chin J Lab Med2002(1)
[17] FRANCO S, OZKAYNAK M F, SANDOVAL C. Telomere dynamics in childhood leukemia and solid tumors:a follow-up study. 2003(2). doi:10.1038/sj.leu.2402815
[18] MARTENS U M, BRASS V, SEDLACEK L. Telomere maintenance in human B lymphocytes. 2002(3). doi:10.1046/j.1365-2141.2002.03910.x
[19] ELWOOD N J. Telomeres biology of human hematopoietic stem cells, 2004(12)
[20] KLEIDEITER E, BANGERTER U, SCHWAB M. Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukemia (T-ALL). 2005(2). doi:10.1038/sj.leu.2403596
[21] 丁家华, 高冲, 廖世兵. 急性白血病不同病期端粒酶活性及其预后意义初探. 东南大学学报(医学版)2001(4). doi:10.3969/j.issn.1671-6264.2001.04.006
[22] ZHANG Y, LIU S Q, QU Y. Preliminary analysis on human telomerase reverse transcriptase gene expression in acute leukemia. Chung Hua I Hsueh Tsa Chih(台湾)2003(1)
[23] TCHIRKOV A, CHALETEIX C, MAGNAC C. hTERT expression and prognosis in B-chronic lymphocytic leukemia. 2004(10). doi:10.1093/annonc/mdh389
[24] BAKALOVA R, OHBA H, ZHELEV Z. Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and up-regulates tankyrase in human leukemia cells, 2004(1-2)
[25] SIEGLOVA Z, ZILOVCOVA S, CERMAK J. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes(MDS) and acute myelogenous leukemia arising from MDS:a marker of disease prognosis. 2004(10). doi:10.1016/j.leukres.2003.11.020
[26] GURKAN E, TANRIVERDI K, BASLAMSLI F. Telomerase activity in myelodysplastic syndromes. 2005(10). doi:10.1016/j.leukres.2005.03.006
[27] LEE J J, NAM C E, CHO S H. Telomere length shortening in non-Hodgkin′s lymphoma patients undergoing chemotherapy, 2003(8)
[28] WU K, ORME L, SHAUGHNESSY J J. Telomerase and telomere length in multiple myeloma:correlations with disease heterogeneity,cytogenetic status,and overall survival. 2003(12)
[29] KOMATA T, KANZAWA T, KONDO Y. Telomerase as a therapeutic target for malignant gliomas. 2002(4). doi:10.1038/sj.onc.1205072
[30] GRYAZNOV S, PONGRACZ K, MATRY T. Telomerase inhibitors:oligonucleotide phosphoramidates as potential therapeutic agents, 2001(47)
[31] MO Y, GAN Y, SONG S. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. 2003
[32] GABRIELE S. Telomerase inhibition as cancer therapy. 2003(2). doi:10.1016/S0304-3835(2)00708-5
[33] LIU L, LAI S, ANDREWS L G. Genetic and epigenetic modulation of telomerase activity in development and disease. 2004(1). doi:10.1016/j.gene.2004.06.011
[34] KOSCIOLEK B A, KALANTIDIS K, TABLER M. Inhibition of telomerase activity in human cancer cells by RNA interference, 2003(3)
[35] KANG S S, KWON T, KWON D Y. Inhibition of telomerase reverse transcriptase subunit. 1999. doi:10.1074/jbc.274.19.13085
[36] WANG E S, WU K D, CHIN A C. Telomerase inhibition with an oligonucleotide telomerase template antagonist:in vitro and in vivo studies in multiple myeloma and lymphoma. 2004(1). doi:10.1182/blood-2003-02-0546 |
